Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
Gyala Therapeutics
Gyala Therapeutics
AVM Biotechnology Inc
Hebei Senlang Biotechnology Inc., Ltd.
Alexion Pharmaceuticals, Inc.
Hebei Senlang Biotechnology Inc., Ltd.
iCell Gene Therapeutics
Angimmune LLC
BioCryst Pharmaceuticals